|
|
|
|
| Symbol(s): |
EMR |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Emerson has a current Overall Rating of B (Positive). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Emerson has a current Overall Rating of B (Positive). Power Rating (78) is high; appreciation potential (49) is neutral. Relative to the S&P 500 Composite, Emerson Co has moderate Growth characteristics -- its appeal is likely to be to investors neutral towards Income. EMR is of the highest investment quality. Current annual total return performance of 14.5% is slightly below median. Current 5-year total return performance of 2.8% is below median. Over the full time period, Emerson's ...
| | |
|
|
